Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |